2
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Hemodynamic and Renal Effects of Atrial Natriuretic Factor (99-126) in Volume Expanded Sheep

, , , &
Pages 1107-1126 | Published online: 23 May 2017

  • Andersson O.K., Persson B., Granerus G., Wysocki M., Anrell M., Hedner T., Hedner J. Release of atrial natriuretic peptide (alpha-hANP) and circulating noradrenaline in relation to central and renal hemodynamics and sodium output during acute volume load in hypertensive and normotensive men. Acta Med Scand 1986; 714: 133–137.
  • Fei D.T.W., Graham W.F., McDougall J.G., Scoggins B.A., Coghlan J.P. [Des-Asp1]-angiotensin II in the sheep. Blood levels and its effects on plasma renin concentration. Life Sci. 1980; 26: 1495–1502.
  • Garcia R., Gutkowska J., Genest J., Cantin M., Thibault G. Reduction in blood pressure and increased diuresis and natriuresis during chronic infusion of ANF (Arg 101-Tyr 126) in conscious one-kidney, one-clip hypertensive rats. Proc Soc Exp Biol Med 1985; 179: 539–545.
  • Hedner J., Hedner T., Towle A.C., Pettersson A., Persson B., Wysocki M., Andersson O.K. Increase in plasma atrial natriuretic peptides during acute volume expansion In hypertensive man. Acta Med Scand 1986; 219: 469–472.
  • Hirth C., Stasch J.P., Hohn A., Kazda S., Morlch F., Neusen D., Wohlfeil S. The renal response to acute hypervolemia is caused by atrial natriuretic peptides. J Cardiovasc Pharmacol 1986; 8: 268–275.
  • Huang D., Guo J., Wang Y., Don H., Zhang T., Dai Y., Que H. Therapeutic effects of α-hANP on hypertensive heart disease with heart failure and oliguria. Chin Med J 1986; 99: 301–303.
  • Ishii M., Sugimoto T., Matsuoka H., Hirata Y., Ishimitsu T., Friku K., Sugimoto T., Kanagawa K., Matsuo H. A comparitive study on the hemodynamic, renal and endocrine effects of α-human atrial natriuretic polypeptide in normotensive persons and patients with essential hypertension. Jpn Cire J 1986; 50: 1181–1184.
  • Ishii M., Sugimoto T., Matsuoka H., Hirata Y., Ishimitsu T., Fukui K., Sugimoto T., Kangawa K., Matsuo H. The haemodynamic, renal and endocrine effects of alpha-human atrial natriuretic polypeptide in normotensive people and patients with essential hypertension. J Hypertens 1986; 4: S 542–545.
  • Kihara M., Nakayama K., Nakao K., Sugawara A., Morii N., Sakamoto M., Suda M., Shimokura A., Kisoy Y., Imura H., Yamori Y. Accelerated natriuresis induced by synthetic atrial natriuretic polypeptide in spontaneously hypertensive rats. Clin Exp Hypertens 1985; A7: 539–551.
  • Kondo K., Kida O., Kangawa K., Matsuo H., Tanaka K. Natriuretic and hypotensive effects of α-human atrial natriuretic polypeptide in anaesthetised doca-salt hypertensive rats. Clin Exp Pharmacol Physiol 1986; 13: 97–101.
  • Maack T., Marion D.N., Camargo M.J.F., Kleinert H.D., Laragh J.H., Vaughan E.D., Atlas S.A. Effects of auriculin (atrial natriuretic factor) on blood pressure, renal function, and the renin-aldosterone system in dogs. Am J Med 1984; 77: 1069–1075.
  • Mills I.H. Atrial natriuretic factor: a new hormone? Br J Med 1984; 289: 210–211.
  • Paganelli W.C., Cant J.R., Barger A.C., Dzau V.J. Influence of acute changes in atrial pressures on plasma atrial natriuretic factor in the conscious dog. J Hypertens 1986; 4: S 516–518.
  • Pang S.C., Hoang M.C., Tremblay J., Cantin M., Garcia R., Genest J., Hamet P. Effect of natural and synthetic atrial natriuretic factor on arterial blood pressure, natriuresis and cyclic GMP excretion in spontaneously hypertensive rats. Clin Sci 1985; 69: 721–726.
  • Parkes D.G., Coghlan J.P., McDougall J.G., Scoggins B.A. Hemodynamic effects of atrial natriuretic peptide in conscious sheep. Clin Exp Hypertens 1987; A9: 2143–2156.
  • Parkes D.G., Coghlan J.P., McDougall J.G., Scoggins B.A. Enhancement of the renal but not hemodynamic effects of atrial natriuretic peptide (1-28) in ACTH treated sheep. Clin Exp Pharmacol Physiol (in press).
  • Parkes D.G., Coghlan J.P., McDougall J.G., Tyers M.A., Scoggins B.A. Atrial natriuretic peptide increases the sensitivity of the baroreceptor reflex in conscious sheep. Proc Aust Soc Med Res 1986; 19: 11.
  • Rascher W., Tulassay T., Lang R.E. Atrial natriuretic peptide in plasma of volume-overloaded children with chronic renal failure. Lancet 1985; II: 303–305.
  • Richards A.M., Nicholls M.G., Ikram H., Webster M.W.I., Yandle T.G., Espiner E.A. Renal, heamodynamic and hormonal effects of human alpha atrial natriuretic peptide in healthy volunteers. Lancet 1985; I: 545–549.
  • Richards A.M., Nicholls M.G., Espiner E.A., Ikram H., Yandle T.G., Joyce S.L., Cullens M.M. Effects of α-human atrial natriuretic peptide in essential hypertension. Hypertension 1985; 7: 812–817.
  • Rutlen D.L., Supple E.N., Powell W. β-Adrenergic regulation of total systemic intravascular volume in the dog. Circ Res 1981; 48: 112–120.
  • Scoggins B.A., Allen K.J.S., Coghlan J.P., Denton D.A., Graham W.F., Humphrey T.J., Whitworth J.A. Hemodynamics of ACTH-induced hypertension in sheep. Clin Sci 1979; 57: 3355–3365.
  • Scoggins B.A., Allen K.J.S., Coghlan J.P., Denton D.A., Fei D.T.W., Tresham J.J., Wang X., Whitworth J.A. Onset and dose-relationships of ACTH effects on blood pressure in sheep. Hypertension 1985; 7: 287–291.
  • Schwab T.R., Edwards B.S., Heublein D.M., Burnet J.C. Role of atrial natriuretic peptide in volume-expansion natriuresis. Am J Physiol 1986; 251: R310-R313.
  • Seymour A.A., Marsh E.A., Mazack E.K., Stabilito I.I., Blaine E.H. Synthetic atrial natriuretic factor in conscious normotensive and hypertensive rats. Hypertension 1985; 4: S 516–518.
  • Trippodo N.C., Cole F.E., MacPhee A., Pegram B.L. Biologie mechanisms of atrial natriuretic factor. J Lab Clin Med 1987; 109: 112–119.
  • Tunny T.J., Gordon R.D., Klemm S.A., Hamlet S.M. Effects of acute volume expansion on atrial natriuretic peptide levels in normal subjects, primary aldosteronism and low-renin essential hypertension. J Hypertens 1986; 4: S 509–511.
  • Walker R.G., Swainson C.P., Yandle T.G., Nicholls M.G., Espiner E.A. Exaggerated responsiveness of immunoreactive atrial natriuretic peptide to saline infusion in chronic renal failure. Clin Sci 1987; 72: 19–24.
  • Weidmann P., Gnadinger M.P., Zisweiler H.R., Shaw S., Bachmann C., Rascher W., Uehlinger D.E., Hasler L., Reubi F.C. Cardiovascular, endocrine and renal effects of atrial natriuretic peptide in essential hypertension. J Hypertens 1986; 4: S 71–83.
  • Yates N.A., McDougall J.G., Coghlan J.P., Coker A.R., Gibson A.P., Scoggins B.A. Renal effects of atrial natriuretic factor (99-126) in conscious euvolemic sheep. Clin Exp Pharmacol Physiol (in press).
  • Yates N.A., McDougall J.G., Coghlan J.P., Denton D.A., Scoggins B.A., Tregear G.W. Sodium depletion decreases the renal responsiveness to atrial natriuretic peptide. Proc High Blood Pressure Research Council of Australia 1985; 7: 5.
  • Yates N.A., Coghlan J.P., McDougall J.G., Scoggins B.A., Wade J.D. Interaction of atrial natriuretic peptide and the reinangiotensin system in the kidney. Proc Endocr Soc Aust 1986; 29: 121.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.